Healthcare Industry News: ultrasound
News Release - September 18, 2018
1st Wireless, Handheld, FDA-approved Ultrasound Device to Offer Live Demos at FMX (Family Medicine Experience) 2018, Booth #722Wireless, app-based technology is positioning the ultrasound to become as ubiquitous as a stethoscope for general practitioners
ROSEVILLE, Calif., Sept. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Healcerion today announced the SONON 300L will be unveiled to the US market with live demos at booth #722 in the New Exhibitor Pavilion at FMX Family Medicine Experience Show 2018, October 9-13, Ernest N. Morial Convention Center, New Orleans, LA.
Dr. Benjamin Ryu, CEO and Founder of Healcerion and creator of the SONON 300L says, "Today, the stethoscope is a symbol of the medical profession. It is the most ubiquitous, recognized diagnostic instrument worldwide. Thanks to wireless technology and innovation, we now have a world-class ultrasound device that fits easily in your hand or your pocket." Dr. Ryu adds, "Primary Care Physicians and other clinicians can try the new SONON 300L wireless, handheld ultrasound device at FMX, and learn how to accelerate diagnosis, gain deeper insight into patient health and provide a richer patient experience, while increasing revenue."
Healcerion is offering a 10% discount for purchases of the SONON 300L for FMX attendees.
This family medicine event is the AAFP's (American Academy of Family Physicians) largest annual meeting. Attendees will gain valuable new family medicine knowledge through exclusive opportunities to engage with the latest developments in health care, patient expectations, treatment guidelines, and technology including the newly launched SONON 300L wireless, handheld ultrasound device.
SONON 300L is smaller and easier to use than any other ultrasound in the US market. It removes the barriers of space and budgetary constraints for acquisition of a diagnostic ultrasound device. As a result, practitioners and patients both benefit.
Ethan M. Kreiswirth, PhD, ATC, Owner of Kreiswirth Sports Medicine Systems and Medical Director and Coordinator for the U.S. Brazilian Jiu-Jitsu Federation said, "I have been using the SONON Wireless Mobile ultrasound Device for the past two months and have had incredible results! Its compact size and user-friendly interface has increased my scanning ability of soft tissue pathology, in addition my capability to assess a multitude of structures within the human body. I'm very excited to share with patients and students how my SONON device can aid in patient care!"
The SONON 300L costs approximately 1/10 of a traditional ultrasound unit. It uses easy touch-screen controls with an app downloaded from the Google Play or Apple App Store. It pairs with a tablet or smartphone as a display, and images can be analyzed and shared quickly. The device weighs only 13 ounces (370 grams) and has a rechargeable lithium-ion battery with industry-leading 3-hour continuous run-time, Wi-Fi connectivity and 3G/LTE cellular capability.
Greg Fritz, PT, RMSK and Owner of Anacortes Physical Therapy says, "I am currently using the SONON 300L and 300C for MSK imaging in the practice of Physical Therapy. I have used the Healcerion handheld scanners in real world situations from acute sports injury assessment to biofeedback training of pelvic floor muscles to remedy stress incontinence. The Healcerion wireless ultrasound scanners are as capable of providing me with quality assessment images as my cart ultrasound system, which is 4 times as expensive and 500 times as heavy!"
Founded in 2012, Healcerion provides healthcare professionals with mobile technology to enhance the quality of medical care available worldwide. The company delivers affordable, high-quality, wireless, handheld ultrasound devices to clinical and remote locations. Through medical and technology innovation, Healcerion removes barriers to life-saving visibility which diagnostic ultrasound provides to those most urgently in-need.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.